Medtech innovator Optellum gets €14 million capital injection to improve lung cancer detection

Published on September 27, 2022

Based in Oxford, Optellum is making an impact breakthrough in medicine through its AI platform. The medtech startup is aiming to bring about earlier diagnosis of lung cancer, enabling early-stage treatments to be made and patient outcomes improved.  Lung cancer is the most common type of cancer and is the leading cause of cancer deaths…

This content is for members only. Visit the site and log in/register to read.

The post Medtech innovator Optellum gets €14 million capital injection to improve lung cancer detection appeared first on EU-Startups.